Alzheimers Treatment
-
A look at life science innovation brought on by physician-biopharm tech hybrids
In this series, Dialogues+ is taking a look at innovation brought about through collaborations between […]
-
J&J takes an early interest in biotech startup Alector’s approach to Alzheimer’s treatment
In another move to potentially beef up its Alzheimer’s pipeline, Johnson & Johnson has struck […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
In gamification milestone, Pfizer will assess video game in clinical trial for Alzheimer’s disease
In a move that could have a significant impact on how pharmaceutical companies view gamification, […]
-
One healthcare market that’s not growing quickly: Alzheimer’s disease drugs
3D printing in medicine is “skyrocketing.” Diabetes drugs comprise a huge market already and are […]
-
Janssen turns to Evotec for help discovering new targets and drugs for Alzheimer’s disease
Despite a major setback last summer when its promising drug bapineuzumab failed in late-stage clinical […]
-
3 neat ways to participate in crowdsourced cancer and Alzheimer’s disease research
Thanks to technology and the changing culture of medicine, those of us who don’t have […]
-
Startup Alzheon’s proposal for Alzheimer’s drug success adds new science to old, failed trials
From a commercial perspective, the last few decades of Alzheimer’s drug development have largely been […]
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Close look at 23andMe founder and what genetic testing means for adoptive parents
What began as an assignment to investigate and profile 23andMe Founder and CEO Anne Wojcicki […]
-
Obesity: A Risk Factor for Alzheimer’s
This post is part of ongoing coverage of Cleveland Clinic’s 2013 Medical Innovation Summit: Finding […]
-
Want to solve your men’s health issue? Grow a mustache, join the Movember movement
Doctor Mike Evans’ Youtube Channel is one of my favorites. Watching “23 1/2 hours” changed […]
-
NeuroTrack’s computer test for Alzheimer’s wins over Founders Fund, Social+Capital Partnership
What if a simple computer test administered in a doctor’s office could foretell which seniors […]
-
Neuro drug developer iPierian nets $30M, spins off new company for rare disease R&D program
Rather than leveraging stem cells for therapeutic use, iPierian Inc. has been using them to […]
-
Devices & Diagnostics, Diagnostics
Navidea’s Alzheimer’s imaging agent moves into Phase 3 with Siemens deal, SBIR grant
Navidea Biopharmaceuticals (NYSE:NAVB) is getting some financial support from the NIH for its Alzheimer’s diagnostic […]